MA, B., J, S., CA, S., & ML, V. (2017). Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway. BMC pharmacology & toxicology, 18(1), 47. https://doi.org/10.1186/s40360-017-0154-5
Chicago Style (17th ed.) CitationMA, Ba, Surina J, Singer CA, and Valencik ML. "Knockdown of Subunit 3 of the COP9 Signalosome Inhibits C2C12 Myoblast Differentiation via NF-KappaB Signaling Pathway." BMC Pharmacology & Toxicology 18, no. 1 (2017): 47. https://doi.org/10.1186/s40360-017-0154-5.
MLA (9th ed.) CitationMA, Ba, et al. "Knockdown of Subunit 3 of the COP9 Signalosome Inhibits C2C12 Myoblast Differentiation via NF-KappaB Signaling Pathway." BMC Pharmacology & Toxicology, vol. 18, no. 1, 2017, p. 47, https://doi.org/10.1186/s40360-017-0154-5.